Sun Pharmaceutical Ltd. has reportedly stated that it is all et to acquire Novartis’ cancer ailment drug named Odomzo for almost 175 million USD. The branded oncology product will be taken under possession soon which was declared during a regulatory filing to stock exchanges with a whopping charge of additional milestone payments apart from the acquisition amounts. The proposed deal,as …

Sun Pharmaceutical Industries recorded 1% high in net profit closing at Rs. 786.25 amid the launch of ready-to-administer oncology solutions. The medicine bag will provide a proper solution in cancer treatment; which came as to be positive for the pharmaceutical company. It made the announcement while thefiling at BSE. As of Sun Pharmaceuticals, 14,000 shares were traded so far in …